Cargando…
Clinical Utility of Liquid Biopsy to Identify Genomic Heterogeneity and Secondary Cancer Diagnoses: A Case Report
Liquid biopsy is a valuable tool in advanced and metastatic cancers for detection of genomic alterations in tumors that facilitate personalized targeted therapy approaches. Analyzing circulating tumor DNA (ctDNA) using next-generation sequencing (NGS) provides an opportunity to detect tumor genomic...
Autores principales: | Hemenway, Gregory, Tierno, Marni B., Nejati, Reza, Sosa, Romina, Zibelman, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921912/ https://www.ncbi.nlm.nih.gov/pubmed/35350808 http://dx.doi.org/10.1159/000521841 |
Ejemplares similares
-
Utility of liquid biopsy in diagnosing isolated cerebral phaeohyphomycosis: illustrative case
por: Arrighi-Allisan, Annie E., et al.
Publicado: (2022) -
Deciphering Tumour Heterogeneity: From Tissue to Liquid Biopsy
por: Gilson, Pauline, et al.
Publicado: (2022) -
Liquid biopsies in primary and secondary bone cancers
por: Ucci, Argia, et al.
Publicado: (2022) -
Utility of Trucut Biopsy in Diagnosing Phyllodes Tumor
por: Chaudhary, Dimple, et al.
Publicado: (2019) -
Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer
por: Huang, Hai‐Ming, et al.
Publicado: (2020)